Estimation of the number of RSV-associated hospitalisations in adults in the European Union
Preprint
Abstract
Background Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections in older adults that can result in hospitalisations and death. Estimating RSV- associated hospitalisation is critical for planning RSV-related healthcare needs for the ageing population across Europe. Methods We gathered national RSV-associated hospitalisation estimates from the REspiratory Syncytial virus Consortium in EUrope (RESCEU) for adults in Denmark, England, Finland, Norway, Netherlands, and Scotland from 2006 to 2017. We extrapolated these estimates to 28 EU countries using nearest-neighbour matching, multiple imputations, and two sets of 10 indicators. Results On average, 158 229 (95%CI: 140 865-175 592) RSV-associated hospitalisations occur annually among adults in the EU (above 18 years); 92% of these hospitalisations occur in adults over 65 years. Among 75-84 years old, the annual average is estimated at 74 519 (95%CI: 69 923-79 115) at a rate of 2.24 (95%CI: 2.10-2.38) per 1000 adults. Among adults aged ≥85 years, the annual average is estimated at 37 904 (95%CI: 32 444-43 363) at a rate of 2.99 (95%CI: 2.56-3.42). Conclusion Our estimates of RSV-associated hospitalisations in older adults are the first analysis integrating available data to provide estimates of the disease burden in this population across the EU. Importantly, for a condition which was considered in the past to be primarily a disease of young children, the average annual hospitalisation estimate in adults was lower but of a similar magnitude to the estimate in young children aged 0-4 years: 158 229 (95%CI: 140 865–175 592) versus 245 244 (95%CI: 224 688 –265 799).Keywords
This publication has 42 references indexed in Scilit:
- Seasonal Incidence of Medically Attended Respiratory Syncytial Virus Infection in a Community Cohort of Adults ≥50 Years OldPLOS ONE, 2014
- Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans diseaseBMC Infectious Diseases, 2014
- Respiratory syncytial virus‐ and human metapneumovirus‐associated emergency department and hospital burden in adultsInfluenza and Other Respiratory Viruses, 2014
- Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like IllnessThe Journal of Infectious Diseases, 2014
- Global Mortality Estimates for the 2009 Influenza Pandemic from the GLaMOR Project: A Modeling StudyPLOS Medicine, 2013
- Medically Attended Respiratory Syncytial Virus Infections in Adults Aged >=50 Years: Clinical Characteristics and OutcomesClinical Infectious Diseases, 2013
- Editorial Commentary: Respiratory Syncytial Virus: A Global Pathogen in an Aging WorldClinical Infectious Diseases, 2013
- High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus InfectionsClinical Infectious Diseases, 2013
- Modelling hospital admissions for lower respiratory tract infections in the elderly in EnglandEpidemiology and Infection, 2006
- The Association of Respiratory Syncytial Virus Infection and Influenza with Emergency Admissions for Respiratory Disease in London: An Analysis of Routine Surveillance DataClinical Infectious Diseases, 2006